The Spanish Association against Cancer (AECC) has awarded an aid to research in Ewing sarcoma, a type of childhood cancer located in bone. The project has a duration of five years and has funding of one million two hundred thousand Euros.

Ewing sarcoma is the second most common bone cancer and affects children and youth. Currently, if diagnosed in time and no metastasis can be cured in 80% of cases but between 25% and 30% of cases are diagnosed when it has metastasized and survival drops to 30%.

The aid has been granted to the multicenter research group on Ewing’s sarcoma consists of physicians and researchers at the University Hospital Virgen del Rocío, Sevilla, led by Enrique de Alava, the San Juan de Dios Hospital with Jaume Mora at front, and the sarcomas research group of the Bellvitge Biomedical Research Institute (IDIBELL) headed by Oscar Martinez-Tirado.

This week the board of the scientific foundation aecc have presented the award of more than 4 millions of Euros in new research projects. Thus, the AECC has committed for 2013 about 14 million Euros in quality cancer research.